Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective
Author:
Funder
Hangzhou Normal University
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference272 articles.
1. https://clinicaltrials.gov. Accessed on April 20, 2020.
2. Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer;Franci;Epigenomics,2010
3. Development and therapeutic impact of HDAC6-selective inhibitors;Dallavalle;Biochem. Pharmacol.,2012
4. Chidamide, a novel histone deacetylase inhibitor, displays potent antitumor activity against MDS cells mainly through JAK2/STAT3 signaling inhibition;Chang;Blood,2015
5. A novel class of anthraquinone-based HDAC6 inhibitors;Song;Eur. J. Med. Chem.,2019
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Bifunctional Conjugates Targeting PD-L1/PARP7 as Dual Immunotherapy for Potential Cancer Treatment;Journal of Medicinal Chemistry;2024-06-24
2. The Advent of Molecular Targeted Therapies Against Cancer. Toward Multi‐Targeting Drugs Through Materials Engineering: A Possible Future Scenario;Small Science;2024-05-28
3. The role of molecular chaperone CCT/TRiC in translation elongation: A literature review;Heliyon;2024-04
4. Design, Synthesis, and Structure–Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition;Journal of Medicinal Chemistry;2024-03-08
5. HDAC/NAMPT dual inhibitors overcome initial drug-resistance in p53-null leukemia cells;European Journal of Medicinal Chemistry;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3